Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 06.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ge Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O |
| 14.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C |
| 09.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | corporated by specific reference in such filing. Item 5.02. Departure of Directors or Certain Officers; Election of Dire |
| 26.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ☒ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Unternehmen & Branche
| Name | electroCore, Inc. |
|---|---|
| Ticker | ECOR |
| CIK | 0001560258 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3845 · Electromedical & Electrotherapeutic Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 50,1 Mio. USD |
| Beta | 0,60 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 32,032,000 | -13,966,000 | -1.65 | 18,667,000 | -1,709,000 |
| 2025-09-30 | 10-Q | 8,689,000 | -3,405,000 | -0.40 | 21,412,000 | -1,073,000 |
| 2025-06-30 | 10-Q | 7,381,000 | -3,671,000 | -0.44 | 14,559,000 | 1,113,000 |
| 2025-03-31 | 10-Q | 6,719,000 | -3,855,000 | -0.47 | 16,041,000 | 4,365,000 |
| 2024-12-31 | 10-K | 25,182,000 | -11,886,000 | -1.59 | 20,471,000 | 7,544,000 |
| 2024-09-30 | 10-Q | 6,554,000 | -2,497,000 | -0.31 | 21,045,000 | 9,455,000 |
| 2024-06-30 | 10-Q | 6,139,000 | -2,655,000 | -0.38 | 22,355,000 | 11,472,000 |
| 2024-03-31 | 10-Q | 5,443,000 | -3,506,000 | -0.53 | 13,890,000 | 4,496,000 |
| 2023-12-31 | 10-K | 16,030,000 | -18,834,000 | -3.42 | 16,102,000 | 7,442,000 |
| 2023-09-30 | 10-Q | 4,508,000 | -4,032,000 | -0.68 | 20,108,000 | 11,040,000 |
| 2023-06-30 | 10-Q | 3,551,000 | -4,903,000 | -1.03 | 14,222,000 | 7,064,000 |
| 2023-03-31 | 10-Q | 2,780,000 | -5,867,000 | -1.24 | 18,300,000 | 11,847,000 |
| 2022-12-31 | 10-K | 8,592,000 | -22,162,000 | -4.69 | 24,756,000 | 17,086,000 |
| 2022-09-30 | 10-Q | 1,976,000 | -5,453,000 | -1.20 | 29,491,000 | 22,204,000 |
| 2022-06-30 | 10-Q | 2,157,000 | -5,337,000 | -1.20 | 33,481,000 | 27,173,000 |
| 2022-03-31 | 10-Q | 1,899,000 | -5,582,000 | -1.20 | 37,181,000 | 31,816,000 |
| 2021-12-31 | 10-K | 5,451,000 | -17,218,070 | -4.36 | 42,833,000 | 36,648,000 |
| 2021-09-30 | 10-Q | 1,487,000 | -3,993,000 | 47,570,749 | 40,480,750 | |
| 2021-06-30 | 10-Q | 1,269,000 | -2,894,000 | 31,297,183 | 23,980,896 | |
| 2021-03-31 | 10-Q | 1,204,000 | -5,384,000 | 33,750,219 | 26,031,814 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-10 | Goldberger Daniel S | Open Market Sale | -16,072 | 6.02 | -96,753.44 | -302,8% | ||
| 2025-12-04 | Lev Joshua S. | Officer, Chief Financial Officer | Open Market Sale | -2,500 | 5.05 | -12,625.00 | -39,5% | |
| 2025-12-02 | Goldberger Daniel S | Director, Officer, Chief Executive Officer | Open Market Purchase | 1,000 | 4.84 | 4,840.00 | +15,1% | |
| 2025-11-12 | Lev Joshua S. | Officer, Chief Financial Officer | Open Market Sale | -2,166 | 6.18 | -13,385.88 | -41,9% | |
| 2025-08-11 | Errico Thomas J. | Director | Open Market Purchase | 15,000 | 4.47 | 67,050.00 | +209,8% | |
| 2025-08-11 | Goldberger Daniel S | Director, Officer, Chief Executive Officer | Open Market Purchase | 1,000 | 4.23 | 4,230.00 | +13,2% | |
| 2025-05-23 | GANDOLFO JOHN P | Director | Open Market Purchase | 1,800 | 5.01 | 9,018.00 | +28,2% | |
| 2025-05-12 | Errico Thomas J. | Director | Open Market Purchase | 10,000 | 4.77 | 47,735.00 | +149,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.